| |
| |
|
| Insider
Information: |
Itri Lorettta M |
| Relationship: |
Officer |
| City: |
Berkeley Heights |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,284,546 |
|
|
Indirect Shares
|
1,121,479,596 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$5,250 |
|
|
| Total
Shares |
1,126,764,142 |
|
|
| Total
Value |
$5,250 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genta Inc De |
GNTAQ |
Pres R&D Chief Medical... |
2011-01-06 |
5,284,546 |
2011-01-06 |
1,121,476,596 |
Premium* |
|
|
Immunomedics Inc |
IMMU |
Chief Medical Officer |
2020-10-23 |
0 |
2020-10-23 |
0 |
Premium* |
|
|
Aadi Bioscience, Inc |
AADI |
Officer |
|
0 |
2021-10-21 |
3,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AADI |
Aadi Bioscience, Inc |
Chief Medical OfficerOfficer |
• – – |
2021-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,000 |
|
% |
|
| IMMU |
Immunomedics Inc |
Chief Medical Officer |
• – – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,000) |
0 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres R&D Chief Medical Officer |
• – – |
2011-01-06 |
4 |
S |
$0.02 |
$38,035 |
D/D |
(2,161,074) |
5,284,546 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres R&D Chief Medical Officer |
• – – |
2011-01-05 |
4 |
S |
$0.02 |
$25,244 |
D/D |
(1,294,543) |
7,445,620 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres R&D Chief Medical Officer |
• – – |
2011-01-05 |
4 |
A |
$0.00 |
$11,058 |
D/D |
3,455,617 |
8,740,163 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres & CMO |
• – – |
2009-12-17 |
4 |
S |
$0.11 |
$15,108 |
D/D |
(137,347) |
9,736,195 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres & CMO |
• – – |
2009-12-16 |
4 |
S |
$0.08 |
$88,122 |
D/D |
(1,101,529) |
9,873,542 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres & CMO |
• – – |
2009-12-15 |
4 |
S |
$0.08 |
$150,028 |
D/D |
(1,875,348) |
10,975,071 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres and Chief Medical Officer |
• – – |
2009-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,071,990 |
12,315,425 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2009-07-15 |
4 |
OE |
$0.10 |
$207,500 |
I/I |
2,075,000 |
5,450,568 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2009-07-15 |
4 |
OE |
$0.10 |
$311,250 |
D/D |
3,112,500 |
5,450,568 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. Pharm Devel & CMO |
• – – |
2008-12-09 |
4 |
A |
$0.00 |
$0 |
I/I |
46,373 |
538,367 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. Pharm Devel & CMO |
• – – |
2008-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
69,560 |
491,994 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2008-12-09 |
4 |
A |
$0.00 |
$0 |
I/I |
69,560 |
613,316 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2008-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
452,141 |
543,756 |
0 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2007-05-15 |
4 |
B |
$0.32 |
$32,000 |
D/D |
100,000 |
369,695 |
2.74 |
- |
|
| GNTAQ |
Genta Inc De |
President, Pharm. Dev. CMO |
• – – |
2006-11-16 |
4 |
B |
$0.76 |
$19,760 |
D/D |
26,000 |
100,000 |
2.74 |
- |
|
| GNTAQ |
Genta Inc De |
Pres. & CMO |
• – – |
2006-11-16 |
4 |
B |
$0.76 |
$19,000 |
D/D |
25,000 |
269,695 |
2.74 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharm. Dev. and CMO |
• – – |
2005-08-17 |
4 |
B |
$1.07 |
$53,500 |
I/I |
50,000 |
244,695 |
1.99 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharm. Dev. and CMO |
• – – |
2005-08-17 |
4 |
B |
$1.05 |
$52,500 |
D/D |
50,000 |
74,000 |
2.74 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharm. Dev. and CMO |
• – – |
2004-11-11 |
4 |
B |
$1.40 |
$168,000 |
I/I |
120,000 |
194,695 |
1.99 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharmaceutical Dev. |
• – – |
2003-11-11 |
4 |
B |
$9.11 |
$18,220 |
I/I |
2,000 |
70,700 |
1.99 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharmaceutical Dev. |
• – – |
2003-11-06 |
4 |
B |
$9.75 |
$19,500 |
I/I |
2,000 |
68,700 |
1.99 |
- |
|
| GNTAQ |
Genta Inc De |
President Pharmaceutical Dev. |
• – – |
2003-11-03 |
4 |
B |
$10.05 |
$9,045 |
I/I |
900 |
66,700 |
1.99 |
- |
|
| GNTAQ |
Genta Inc De |
officerTitle |
• – – |
2003-09-25 |
4 |
B |
$13.40 |
$67,000 |
I/I |
5,000 |
65,800 |
1.99 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
